Habib Hamidi
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 5%
- Reproductive Medicine top 2%
- Co-authors
- Dennis J. SlamonGottfried E. KonecnyChen WangEllen L. GoodeCharles GintherJason R. WildSusan E. BatesBoris Winterhoff
- Topics
- Cancer Immunotherapy and Biomarkers (8 papers)Multiple Myeloma Research and Treatments (7 papers)Renal cell carcinoma treatment (5 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Habib Hamidi
36 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 685
- Oncology 437
- Pulmonary and Respiratory Medicine 335
- Cancer Research 310
- Reproductive Medicine 250
Countries citing papers authored by Habib Hamidi
This map shows the geographic impact of Habib Hamidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Habib Hamidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Habib Hamidi more than expected).
Fields of papers citing papers by Habib Hamidi
This network shows the impact of papers produced by Habib Hamidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Habib Hamidi. The network helps show where Habib Hamidi may publish in the future.
Co-authorship network of co-authors of Habib Hamidi
This figure shows the co-authorship network connecting the top 25 collaborators of Habib Hamidi. A scholar is included among the top collaborators of Habib Hamidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Habib Hamidi. Habib Hamidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 0 | |
| 8 | 13 | |
| 9 | 1 | |
| 10 | 10 | |
| 11 | 1 | |
| 12 | 8 | |
| 13 | 1 | |
| 14 | 4 | |
| 15 | 26 | |
| 16 | 40 | |
| 17 | 267 | |
| 18 | 59 | |
| 19 | 56 | |
| 20 | 27 |
About Habib Hamidi
Habib Hamidi is a scholar working on Hematology, Cancer Research and Oncology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Reproductive Medicine (250 citations), Cancer Research (310 citations) and Oncology (437 citations). Habib Hamidi has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Dennis J. Slamon, Gottfried E. Konecny, Chen Wang, Ellen L. Goode, Charles Ginther, Jason R. Wild, Susan E. Bates, Boris Winterhoff, Jerry J. Jaboin and Robert W. Robey. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.